Clinical Trials Directory

Trials / Unknown

UnknownNCT03627338

Medication Adherence in Patients With Liver Cirrhosis

Medikamentenadhärenz Bei Patientinnen Und Patienten Mit Leberzirrhose

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Hannover Medical School · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers

Summary

With this unfunded, investigator-initiated prospective, observational, explorative, single-arm and diagnostic single-centre study the investigators aim to evaluate medication adherence in patients with advanced liver cirrhosis

Detailed description

The main objective of the study is to investigate drug adherence in cirrhotic patients and to gain a better understanding of the causes of deficient adherence including evaluation for medication beliefs, satisfaction, depression, anxiety and health-related quality of life. A number of long-term medications have been approved for this group of patients in various indications and / or recommended by guidelines. However, adherence has not been adequately investigated yet. The investigators aim to focus on the following groups of ingredients / classes: * Primary and secondary antibiotic prophylaxis (e.g. Norfloxacin) * Non-selective beta-blockers (e.g. Carvedilol and Propranolol) * diuretics (Spirolactones \[e.g. Spironolacton\], loop diuretics) Methodically, this is will be investigated in particular by taking into account the patients history, standardized questionnaires and validated interviews.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTquestionaire, interviewquestionaire, interview

Timeline

Start date
2018-09-01
Primary completion
2021-03-31
Completion
2021-05-31
First posted
2018-08-13
Last updated
2020-03-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03627338. Inclusion in this directory is not an endorsement.